FISHER MARY
SEC CIK 1272360 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| DRMA | Dermata Therapeutics, Inc. | Dir | 196.9K | — | — | 4 | 2022-04-07 | 2025-01-21 |
Most active insiders at DRMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs | $1,270 | — |
| 2 | Scott Kathleen D. | Dir | — | $13.09 |
| 3 | Van Hoose Kyri K. | SVP, CFO | — | — |
| 4 | PROEHL GERALD T | Pres, COB, CEO, Dir, 10% | — | — |
FISHER MARY made no open-market trades at DRMA in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-23 | 2025-01-21 | DRMA | Dermata Therapeutics, Inc. | FISHER MARY | Dir | A - Grant | — | +196.9K | 196.9K | +207,212% | — |
| 2022-10-07 | 2022-10-06 | DRMA | Dermata Therapeutics, Inc. | FISHER MARY | Dir | A - Grant | $0.00 | +9,810 | 23.4K | +72% | $0 | |
| 2022-07-08 | 2022-07-07 | DRMA | Dermata Therapeutics, Inc. | FISHER MARY | Dir | A - Grant | $0.00 | +8,602 | 13.6K | +171% | $0 | |
| 2022-04-08 | 2022-04-07 | DRMA | Dermata Therapeutics, Inc. | FISHER MARY | Dir | A - Grant | $0.00 | +5,031 | 5,031 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations